genistein
GeneID | Mean_1 | Mean_2 | StDev_1 | StDev_2 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 196 | 9.6 | 9.4 | 0.3 | 0.7 | -0.393 | 0.7248 | AHR | aryl hydrocarbon receptor |
2 | 367 | 12.4 | 11.5 | 0.1 | 0.2 | -6.768 | 0.0025 | AR | androgen receptor |
3 | 79915 | 6.9 | 6.8 | 0.3 | 1.1 | -0.201 | 0.8578 | ATAD5 | ATPase family, AAA domain containing 5 |
4 | 1544 | 5.9 | 4.8 | 0.3 | 0.4 | -4.317 | 0.0144 | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
5 | 1557 | 2.5 | 2.6 | 0.1 | 0.3 | 0.024 | 0.9825 | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 |
6 | 1576 | 3.5 | 4.1 | 0.8 | 0.4 | 1.209 | 0.3145 | CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 |
7 | 2099 | 11.4 | 8.5 | 0.1 | 0.3 | -16.360 | 0.0014 | ESR1 | estrogen receptor 1 |
8 | 2100 | 2.8 | 3.0 | 0.4 | 0.4 | 0.535 | 0.6213 | ESR2 | estrogen receptor 2 (ER beta) |
9 | 2629 | 11.2 | 10.6 | 0.1 | 0.2 | -4.574 | 0.0253 | GBA | glucosidase, beta, acid |
10 | 2669 | 4.3 | 5.3 | 0.6 | 1.0 | 1.452 | 0.2383 | GEM | GTP binding protein overexpressed in skeletal muscle |
11 | 3248 | 3.1 | 3.8 | 0.2 | 0.6 | 1.952 | 0.1583 | HPGD | hydroxyprostaglandin dehydrogenase 15-(NAD) |
12 | 80271 | 10.9 | 11.1 | 0.3 | 0.1 | 1.119 | 0.3633 | ITPKC | inositol-trisphosphate 3-kinase C |
13 | 4780 | 3.0 | 2.7 | 0.8 | 0.3 | -0.563 | 0.6169 | NFE2L2 | nuclear factor, erythroid 2-like 2 |
14 | 4864 | 7.9 | 8.2 | 0.3 | 0.2 | 1.729 | 0.1663 | NPC1 | Niemann-Pick disease, type C1 |
15 | 190 | 2.8 | 2.7 | 0.5 | 0.3 | -0.233 | 0.8293 | NR0B1 | nuclear receptor subfamily 0, group B, member 1 |
16 | 9971 | 2.4 | 2.4 | 0.0 | 0.1 | 0.713 | 0.5450 | NR1H4 | nuclear receptor subfamily 1, group H, member 4 |
17 | 8856 | 2.2 | 2.3 | 0.0 | 0.0 | 0.733 | 0.5359 | NR1I2 | nuclear receptor subfamily 1, group I, member 2 |
18 | 2908 | 9.6 | 11.8 | 0.2 | 0.2 | 13.075 | 0.0004 | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
19 | 5071 | 3.7 | 3.0 | 0.7 | 0.1 | -1.581 | 0.2478 | PARK2 | parkin RBR E3 ubiquitin protein ligase |
20 | 11040 | 9.6 | 9.2 | 0.4 | 1.2 | -0.513 | 0.6510 | PIM2 | Pim-2 proto-oncogene, serine/threonine kinase |
21 | 5467 | 8.2 | 7.4 | 0.1 | 0.2 | -4.985 | 0.0109 | PPARD | peroxisome proliferator-activated receptor delta |
22 | 5468 | 2.3 | 4.5 | 0.0 | 1.4 | 2.825 | 0.1057 | PPARG | peroxisome proliferator-activated receptor gamma |
23 | 9367 | 11.6 | 12.0 | 0.1 | 0.2 | 2.647 | 0.1013 | RAB9A | RAB9A, member RAS oncogene family |
24 | 6256 | 14.1 | 13.5 | 0.1 | 0.1 | -7.644 | 0.0024 | RXRA | retinoid X receptor, alpha |
25 | 6595 | 9.0 | 8.6 | 0.2 | 0.3 | -2.198 | 0.1035 | SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
26 | 6607 | 6.0 | 6.9 | 0.2 | 0.1 | 6.276 | 0.0175 | SMN2 | survival of motor neuron 2, centromeric |
27 | 55775 | 11.6 | 11.7 | 0.0 | 0.1 | 2.150 | 0.1386 | TDP1 | tyrosyl-DNA phosphodiesterase 1 |
28 | 7066 | 3.6 | 3.1 | 0.4 | 0.6 | -1.093 | 0.3418 | THPO | thrombopoietin |
29 | 7153 | 10.3 | 10.6 | 0.2 | 0.0 | 3.332 | 0.0701 | TOP2A | topoisomerase (DNA) II alpha 170kDa |
30 | 7155 | 13.4 | 13.2 | 0.0 | 0.2 | -1.245 | 0.3366 | TOP2B | topoisomerase (DNA) II beta 180kDa |
31 | 7157 | 7.9 | 7.5 | 0.3 | 0.6 | -0.853 | 0.4589 | TP53 | tumor protein p53 |